Auto-generated from public data. Not the firm's stated position.
Aravis Ventures appears to focus on life sciences investments, particularly in biotech and therapeutics innovation, with a concentration on series-A through growth-stage companies. Based on disclosed data, the firm deploys checks of approximately €3.0M or higher and maintains a portfolio concentrated in specialty pharmaceuticals and therapeutic development across multiple geographies.
Generated 7 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Auto-detected from Aravis Ventures's website.
Economist and CFA with deep experience in infrastructure, utilities, and sustainable growth advisory.
Led and supervised over 100 private equity investments worldwide since 1994, founded Aravis in 2001.
PhD in Biophysics and MBA, participated in life science company financing and M&A transactions.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.